Clinical Trials Browser

Phase 3 × Oropharyngeal Neoplasms × Gabapentin × Clear all

NCT03269344 2022-01-26

Gabapentin for the Reduction of Radiation Therapy Induced Pain During the Treatment of Oropharyngeal Cancer

Phase 3 Completed

65 enrolled 18 charts

Oropharyngeal Neoplasms